Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.

29,885 people played the daily Crossword recently. Can you solve it faster than others?29,885 people played the daily Crossword recently. Can you solve it faster than others? A woman regained ...

智通财经获悉，周四，Allurion(ALUR.US)股价收涨超21%；截至发稿，股价在盘后交易中进一步飙升80%，此前有消息称该公司计划将 ...

Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a ...

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a ...

Investing.com -- Shares of Allurion Technologies (NYSE: ALUR) skyrocketed by 350% following the company's announcement of its plans to initiate a clinical study aimed at optimizing muscle mass during ...

Shares fall 4.3%, to $191.93, in postmarket trading. Allurion Technologies said it would initiate a clinical study on the combination of certain weight-loss drugs and its Allurion program with the ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a definitive ...

Shares of Allurion Technologies (ALUR, Financials) surged 185% to $10.54 in midday trading after the company announced plans to raise $7.4 million through a direct offering. Subject to shareholder ...